Evidence map›Paper›PMID 42426452›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Androgen Receptor Splice Variant-7 Expression Analysis in Circulating Tumor Cells: Methodology and Application of AdnaTest in Prostate Cancer Research.

Naoya Nagaya, Shigeo Horie

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Naoya NagayaDepartment of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shigeo HorieDepartment of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan. shorie@juntendo.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This chapter outlines a detailed methodology for the analysis of androgen receptor splice variant-7 (AR-V7) expression in circulating tumor cells (CTCs) using the AdnaTestProstate CancerSelect and ProstateCancerDetect system. The method incorporates immunomagnetic enrichment, mRNA isolation, and reverse transcription PCR to detect AR-V7, a key marker associated with treatment resistance in castration-resistant prostate cancer (CRPC). The protocol includes step-by-step instructions for sample preparation, magnetic bead-based enrichment, and gene expression analysis, providing a robust platform to investigate the molecular characteristics of CTCs and their roles in therapy resistance.

Indexed as

Gene Expression ProfilingNeoplastic Cells, CirculatingProstatic NeoplasmsProstatic Neoplasms, Castration-ResistantReceptors, AndrogenAlternative SplicingBiomarkers, TumorCell Line, TumorGene Expression Regulation, NeoplasticHumansImmunomagnetic SeparationMaleProtein IsoformsReverse Transcriptase Polymerase Chain ReactionRNA, MessengerAR protein, humanBiomarkers, TumorProtein IsoformsReceptors, AndrogenRNA, MessengerAdnaTestAR-V7Circulating tumor cellsmRNAProstate cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.